Paloma Partners’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-65,585
| Closed | -$395K | – | 2048 |
|
|
2019
Q4 | $395K | Buy |
65,585
+52,785
| +412% | +$318K | 0.01% | 1283 |
|
|
2019
Q3 | $46K | Sell |
12,800
-14,630
| -53% | -$52.6K | ﹤0.01% | 1551 |
|
|
2019
Q2 | $74K | Buy |
+27,430
| New | +$74K | ﹤0.01% | 1397 |
|
|
2018
Q4 | – | Sell |
-26,400
| Closed | -$97K | – | 1537 |
|
|
2018
Q3 | $97K | Buy |
+26,400
| New | +$97K | ﹤0.01% | 1159 |
|
|
2018
Q1 | – | Sell |
-13,865
| Closed | -$40K | – | 1702 |
|
|
2017
Q4 | $40K | Buy |
+13,865
| New | +$40K | ﹤0.01% | 1218 |
|
|
2017
Q3 | – | Sell |
-13,200
| Closed | -$61K | – | 1900 |
|
|
2017
Q2 | $61K | Buy |
+13,200
| New | +$61K | ﹤0.01% | 1591 |
|
|
2015
Q2 | – | Sell |
-33,051
| Closed | -$326K | – | 1766 |
|
|
2015
Q1 | $326K | Buy |
+33,051
| New | +$326K | 0.01% | 828 |
|